Company Name or Ticker Symbol
Search for other Categories
Pernix Therapeutics Holdings, Inc.  (PTX)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations


Deficit Bigger Than a Year Ago, Topline Crumbles

decrease font size NEWS BETA Increase font size

Pernix Therapeutics Holdings, Inc announced first quarter 2017 operating loss of $-20.094 millions

For the first quarter 2017 Pernix Therapeutics Holdings, Inc losses widen of $-2.94 per share compare to $-0.18 a year ago and improved from $-2.99 per share from the previous quarter.

Sales faded by -38.82 % to $30 millions from $49 millions in the same quarter a year ago and sequentially Sales fell by -28.28 % from $41 millions.

For the first quarter 2017 Pernix Therapeutics Holdings, Inc realized net loss of $-29 million, bigger than $-11 million a year ago.
Other PTX's Earnings Reports

Pernix Therapeutics Holdings reported third quarter 2016 earnings

Pernix Therapeutics Holdings reported second quarter 2016 earnings

Pernix Therapeutics Holdings reported first quarter 2016 earnings

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com